The Effects of Perioperative Gender-affirming Hormone Therapy on Facial Feminization Surgery Adverse Events, Facial Features Addressed, and Esthetic Satisfaction: A Multimodal Analysis.
Laspro M, Hoffman A, et al. • The Journal of craniofacial surgery • 2025
There is a paucity of data to assess the safety or harm of continuing GAHT in the FFS perioperative period, and a shared provider-patient decision-making process examining the risks and benefits of GAHT perioperative continuation is warranted.
Key Findings
Results
VTE incidence was numerically higher in patients who stopped GAHT perioperatively compared to those who continued it.
602 patients stopped GAHT, of whom 3 VTEs were recorded (0.49%)
925 patients continued GAHT perioperatively, with only 1 VTE recorded (0.11%)
Laspro M, Hoffman A, Chinta S, Abdalla J, Tran D, Oh C, et al.. (2025). The Effects of Perioperative Gender-affirming Hormone Therapy on Facial Feminization Surgery Adverse Events, Facial Features Addressed, and Esthetic Satisfaction: A Multimodal Analysis.. The Journal of craniofacial surgery. https://doi.org/10.1097/SCS.0000000000010840